Strumento inattivo

Altre lingue Vifor Pharma AG Other OTC

Azioni

GNHAY

US92674R1023

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

European Commission Solicits Feedback on Vifor Pharma's Anticompetition Commitments	19/04
CSL Vifor Announces Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis	02/05/23
Vifor: l'action déclarée nulle, décotation le 23 décembre	14/12/22
Court Cancels Public Shares of Vifor Pharma after Merger with CSL	14/12/22
Vifor-Aktien werden am 23. Dezember dekotiert	14/12/22
Cancellation of remaining publicly held registered shares of Vifor Pharma AG	14/12/22
CSL Vifor et Fresenius obtiennent le feu vert en Chine pour Ferinject	28/11/22
Ferinject® approved in Chinafor the treatment of iron deficiency in adult patients	28/11/22
Iron Deficiency Day 2022: CSL Vifor calls to take iron seriously	25/11/22
Rhythm Biosciences Expands Executive Management Team, Registers Diagnostic Blood Test With New Zealand	03/11/22
Vifor toujours exempté de certaines obligations de publier	20/10/22
Approval of extension of exemptions from SIX disclosure and publicity obligations	20/10/22
Australia's CSL raises annual profit forecast on Swiss acquisition	17/10/22
Global markets live: Darktrace, Intel, Twitter, Meta, Uber...	12/10/22
Résumé des principales informations économiques du mercredi 12 octobre 2022	12/10/22
Retrait de la cote en vue pour les actions de Vifor	12/10/22
Bolsa de Madrid: El peso de las palabras	12/10/22
Le poids des mots	12/10/22
EN DIRECT DES MARCHES : LVMH, Eutelsat, Stellantis, BNP Paribas, Vicat, Philips, Credit Suisse, Cameco, Intel...	12/10/22
Vifor erhält Genehmigung für Dekotierung von der Schweizer Börse	12/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Vifor Pharma AG Other OTC

Azioni

GNHAY

US92674R1023

Altre lingue

Filtri